[HTML][HTML] Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease
A Gómez-Pascual, T Naccache, J Xu… - Computers in Biology …, 2024 - Elsevier
Background Alzheimer's disease (AD) is a neurodegenerative condition for which there is
currently no available medication that can stop its progression. Previous studies suggest that …
currently no available medication that can stop its progression. Previous studies suggest that …
Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease
A Gómez-Pascual, T Naccache, J Xu… - … in biology and … - pubmed.ncbi.nlm.nih.gov
Background Alzheimer's disease (AD) is a neurodegenerative condition for which there is
currently no available medication that can stop its progression. Previous studies suggest that …
currently no available medication that can stop its progression. Previous studies suggest that …
Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease
A Gómez-Pascual, T Naccache, X Jin… - … IN BIOLOGY AND …, 2024 - boa.unimib.it
Background: Alzheimer's disease (AD) is a neurodegenerative condition for which there is
currently no available medication that can stop its progression. Previous studies suggest that …
currently no available medication that can stop its progression. Previous studies suggest that …
Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease.
A Gómez-Pascual, T Naccache, J Xu… - Computers in Biology …, 2024 - europepmc.org
Background Alzheimer's disease (AD) is a neurodegenerative condition for which there is
currently no available medication that can stop its progression. Previous studies suggest that …
currently no available medication that can stop its progression. Previous studies suggest that …
Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease
A Gómez-Pascual, T Naccache, X Jin… - … IN BIOLOGY AND …, 2024 - boa.unimib.it
Background: Alzheimer's disease (AD) is a neurodegenerative condition for which there is
currently no available medication that can stop its progression. Previous studies suggest that …
currently no available medication that can stop its progression. Previous studies suggest that …
Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease
A Gómez-Pascual, T Naccache, J Xu… - … in Biology and …, 2024 - research.regionh.dk
BACKGROUND: Alzheimer's disease (AD) is a neurodegenerative condition for which there
is currently no available medication that can stop its progression. Previous studies suggest …
is currently no available medication that can stop its progression. Previous studies suggest …
Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease
A Gómez-Pascual, T Naccache… - … in Biology and …, 2024 - cris.maastrichtuniversity.nl
Background: Alzheimer's disease (AD) is a neurodegenerative condition for which there is
currently no available medication that can stop its progression. Previous studies suggest that …
currently no available medication that can stop its progression. Previous studies suggest that …